Literature DB >> 9733704

IS481 and IS1002 of Bordetella pertussis create a 6-base-pair duplication upon insertion at a consensus target site.

S Stibitz1.   

Abstract

The insertion sequence IS481 and its isoform IS1002 have been observed to transpose into the bvgAS locus of Bordetella pertussis, for which the DNA sequence has previously been determined. Upon insertion of IS481 at three different sites and IS1002 at one site, a 6-bp sequence originally present was found at the junction of bvg and insertion sequence DNA. This indicates that, contrary to prior reports, IS481 and IS1002 do create a duplication upon insertion. In this light, examination of these and other examples of IS481 and IS1002 reported in the literature leads to the observation that the 6-bp recognition sequence usually fits the consensus NCTAGN. The near-palindromic nature of this sequence, when directly repeated at the ends of IS481 or IS1002, apparently led to the interpretation that 5 of these base pairs were part of the terminal inverted repeats flanking these elements.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733704      PMCID: PMC107526     

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  7 in total

Review 1.  Insertion sequences.

Authors:  J Mahillon; M Chandler
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

2.  Mutations affecting the alpha subunit of Bordetella pertussis RNA polymerase suppress growth inhibition conferred by short C-terminal deletions of the response regulator BvgA.

Authors:  S Stibitz
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

3.  Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution.

Authors:  A van der Zee; S Vernooij; M Peeters; J van Embden; F R Mooi
Journal:  Microbiology       Date:  1996-12       Impact factor: 2.777

4.  Nucleotide sequence and characterization of a repetitive DNA element from the genome of Bordetella pertussis with characteristics of an insertion sequence.

Authors:  M A McLafferty; D R Harcus; E L Hewlett
Journal:  J Gen Microbiol       Date:  1988-08

5.  Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction.

Authors:  E M Glare; J C Paton; R R Premier; A J Lawrence; I T Nisbet
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

6.  Use of pulsed-field gel electrophoresis for epidemiological study of Bordetella pertussis in a whooping cough outbreak.

Authors:  Y R de Moissac; S L Ronald; M S Peppler
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

7.  The differentiation of Bordetella parapertussis and Bordetella bronchiseptica from humans and animals as determined by DNA polymorphism mediated by two different insertion sequence elements suggests their phylogenetic relationship.

Authors:  A van der Zee; H Groenendijk; M Peeters; F R Mooi
Journal:  Int J Syst Bacteriol       Date:  1996-07
  7 in total
  12 in total

1.  Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate.

Authors:  Karine Dalet; Christian Weber; Laurent Guillemot; Elisabeth Njamkepo; Nicole Guiso
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

2.  Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii.

Authors:  U Reischl; N Lehn; G N Sanden; M J Loeffelholz
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  The History of Bordetella pertussis Genome Evolution Includes Structural Rearrangement.

Authors:  Michael R Weigand; Yanhui Peng; Vladimir Loparev; Dhwani Batra; Katherine E Bowden; Mark Burroughs; Pamela K Cassiday; Jamie K Davis; Taccara Johnson; Phalasy Juieng; Kristen Knipe; Marsenia H Mathis; Andrea M Pruitt; Lori Rowe; Mili Sheth; M Lucia Tondella; Margaret M Williams
Journal:  J Bacteriol       Date:  2017-03-28       Impact factor: 3.490

4.  ISAfe1, an ISL3 family insertion sequence from Acidithiobacillus ferrooxidans ATCC 19859.

Authors:  D S Holmes; H L Zhao; G Levican; J Ratouchniak; V Bonnefoy; P Varela; E Jedlicki
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

5.  E622, a miniature, virulence-associated mobile element.

Authors:  John Stavrinides; Morgan W B Kirzinger; Federico C Beasley; David S Guttman
Journal:  J Bacteriol       Date:  2011-11-11       Impact factor: 3.490

6.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

7.  Rapid detection of Bordetella pertussis by real-time PCR using SYBR green I and a LightCycler instrument.

Authors:  S K Poddar
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

8.  Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis.

Authors:  Hyun-Ja Han; Asaomi Kuwae; Akio Abe; Yoshichika Arakawa; Kazunari Kamachi
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

9.  Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.

Authors:  Nao Otsuka; Hyun-Ja Han; Hiromi Toyoizumi-Ajisaka; Yukitsugu Nakamura; Yoshichika Arakawa; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

10.  Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.

Authors:  Connie Lam; Sophie Octavia; Lawrence Ricafort; Vitali Sintchenko; Gwendolyn L Gilbert; Nicholas Wood; Peter McIntyre; Helen Marshall; Nicole Guiso; Anthony D Keil; Andrew Lawrence; Jenny Robson; Geoff Hogg; Ruiting Lan
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.